A

Ashvattha Therapeutics

0 followers

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.

Industries

Employees

11-50

Links

Org chart

Jeffrey L. Cleland's profile picture
Jeffrey L. Cleland
Chairman, President & CEO
Profile photo

Jeffrey L. Cleland

Collapse
Steve Carlos' profile picture
Steve Carlos
VP, Manufacturing
Elizabeth Torrelio's profile picture
Elizabeth Torrelio
Head, Program Management
Natacha Le Moan
Head, Translational Biology
Debra Nguyen's profile picture
Debra Nguyen
Sr. Manager, Accounting
Jay Z.'s profile picture
Jay Z.
Board Director
Jeannie Skinner's profile picture
Jeannie Skinner
Head of Regulatory Affairs
Jennifer Herber
Associate Director
Mark Feng
Director, Analytical Development
Christine S.
Director, Project Management
Naze Gul Avci, Ph.D.
Senior Scientist
  1. Something went wrong loading the org chart, please refresh the page.